A novel, disruptive vaccination technology: Self-adjuvanted RNActive(®) vaccines

Nucleotide based vaccines represent an enticing, novel approach to vaccination. We have developed a novel immunization technology, RNActive(®) vaccines, that have two important characteristics: mRNA molecules are used whose protein expression capacity has been enhanced by 4 to 5 orders of magnitude...

Descripción completa

Detalles Bibliográficos
Autores principales: Kallen, Karl-Josef, Heidenreich, Regina, Schnee, Margit, Petsch, Benjamin, Schlake, Thomas, Thess, Andreas, Baumhof, Patrick, Scheel, Birgit, Koch, Sven D, Fotin-Mleczek, Mariola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906413/
https://www.ncbi.nlm.nih.gov/pubmed/23921513
http://dx.doi.org/10.4161/hv.25181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906413/
https://www.ncbi.nlm.nih.gov/pubmed/23921513
http://dx.doi.org/10.4161/hv.25181

Ejemplares similares